Goldman Sachs raised its rating on Bruker Corporation (NASDAQ: BRKR ) from Neutral to Buy and raised its price target from $13 to $19. Goldman Sachs commented, "We upgrade shares of Bruker (BRKR) to Buy from Neutral and raise our 12-month price target to $19 (from $13), which implies